Evidence map›Paper›PMID 28086966›Full record

ArticleLipids in health and disease2017

Predictive value of non-fasting remnant cholesterol for short-term outcome of diabetics with new-onset stable coronary artery disease.

Li-Feng Hong, Xiao-Ni Yan, Zhen-Hua Lu, Ying Fan, Fei Ye, Qiong Wu, Song-Hui Luo, Bo Yang, Jian-Jun Li

Open access · goldFull text read
In one paragraph

Article in Lipids in health and disease, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 48 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Observational
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Remnant Cholesterol is an Independent Predictor of New-Onset Diabetes: A Single-Center Cohort Study.Diabetes, metabolic syndrome and obesity : targets and therapy · 2021
    Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Li-Feng HongDepartment of Cardiology, the Fifth Hospital of Wuhan & Cardiovascular Institute of Jianghan University, Wuhan, 430050, China. lifenghong@hotmail.com.
Xiao-Ni YanDepartment of Cardiology, the Fifth Hospital of Wuhan & Cardiovascular Institute of Jianghan University, Wuhan, 430050, China.
Zhen-Hua LuDepartment of Cardiology, the Fifth Hospital of Wuhan & Cardiovascular Institute of Jianghan University, Wuhan, 430050, China.
Ying FanDepartment of Cardiology, the Fifth Hospital of Wuhan & Cardiovascular Institute of Jianghan University, Wuhan, 430050, China.
Fei YeDepartment of Cardiology, the Fifth Hospital of Wuhan & Cardiovascular Institute of Jianghan University, Wuhan, 430050, China.
Qiong WuDepartment of Cardiology, the Fifth Hospital of Wuhan & Cardiovascular Institute of Jianghan University, Wuhan, 430050, China.
Song-Hui LuoDepartment of Cardiology, the Fifth Hospital of Wuhan & Cardiovascular Institute of Jianghan University, Wuhan, 430050, China.
Bo YangDepartment of Cardiology, Renmin Hospital of Wuhan University, Wuhan, China.
Jian-Jun LiDivision of Dyslipidemia, State Key Laboratory of Cardiovascular Disease, Fu Wai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China.
Jianghan University · CNFu Wai Hospital · CNWuhan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe relationship between non-fasting remnant cholesterol and cardiovascular outcome in the era of potent statin therapy remained to be elucidated.

methodsA cohort study of three hundred and twenty eight diabetics diagnosed with new-onset stable coronary artery disease (CAD) by coronary angiography were enrolled. All cases were followed up for an average duration of twelve months. The association between baseline remnant cholesterol levels and major cardiovascular outcomes were evaluated using the receivers operating characteristic (ROC) curves and Cox proportional hazards regression analysis.

resultsDuring a period of 12-month's follow-up, 14.3% patients (47/328) underwent pre-specified adverse outcomes. The remnant cholesterol associated with high sensitivity C-reactive protein, neutrophil count and fibrinogen (R

conclusionsNon-fasting remnant cholesterol was associated with inflammatory biomarkers and high incidence of revascularization, but not qualified as an independent predictor for short-term prognosis of diabetics with new-onset stable coronary artery disease.

Indexed as

AgedBiomarkersCholesterolCholesterol, HDLCholesterol, LDLClopidogrelCohort StudiesCoronary AngiographyCoronary Artery DiseaseC-Reactive ProteinDiabetes Mellitus, Type 2FemaleFibrinogenFollow-Up StudiesGlycated HemoglobinHumansBiomarkersCholesterolCholesterol, HDLCholesterol, LDLClopidogrelC-Reactive ProteinFibrinogenGlycated Hemoglobinhemoglobin A1c protein, humanHydroxymethylglutaryl-CoA Reductase InhibitorsTiclopidineCoronary artery diseaseDiabetic mellitusLow density lipoprotein cholesterolOutcomeRemnant cholesterol

Identifiers

PMID28086966
PMCPMC5237249
OpenAlexW2571888369

What OpenQuestion holds

Textfull text, public
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.